Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Trial Results Fail To Support Mainstay Medical's Neuromodulation Device

19 Nov 2018

• By Catherine Longworth

ReActiv8 — • Source: Mainstay Medical

Related Content

Mainstay Medical Reaches Milestone With Interim Results Of US Clinical Trial

14 Dec 2017

Related Companies

Mainstay Medical International plc

Additional Topics

Clinical Trials Commercial Companies Neurology Medical Device

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.